Updated Sep 2, 2026
/Trump and Rubio seal Venezuela oil deal covering 65 billion barrels across 17 fields/Bond rout gathers pace as borrowing costs hit multi-decade highs/Van Jones calls El-Sayed's total Israel arms embargo 'insane,' cites Obama legacy on defense/Memecoin buys on Robinhood Wallet and Fomo coded as "digital media," sidestepping card-network crypto rules/Caring Brands (CABR) Closes $4.6 Million Initial Series B Preferred Stock Private Placement/Sanmar Group takes majority stake in AltEons Energy to back 1.5GW India pipeline/Trump and Rubio seal Venezuela oil deal covering 65 billion barrels across 17 fields/Bond rout gathers pace as borrowing costs hit multi-decade highs/Van Jones calls El-Sayed's total Israel arms embargo 'insane,' cites Obama legacy on defense/Memecoin buys on Robinhood Wallet and Fomo coded as "digital media," sidestepping card-network crypto rules/Caring Brands (CABR) Closes $4.6 Million Initial Series B Preferred Stock Private Placement/Sanmar Group takes majority stake in AltEons Energy to back 1.5GW India pipeline
NewsSOS
← NewswireMarkets

GeneDx Holdings Corp. Hit With Federal Securities Class Action, Law Firm Tells Investors to Act

DJS Law Group has filed a class action lawsuit against GeneDx Holdings Corp. (NASDAQ: WGS), alleging the company violated federal securities statutes that prohibit fraudulent conduct in connection with the purchase or sale of securities. The Los Angeles-based law firm announced the litigation on June 29, 2026, and is urging affected investors to come forward.

By Corinne Ashford2 min read
Share

Key takeaways

  • DJS Law Group has filed a federal securities class action lawsuit against GeneDx Holdings Corp. (NASDAQ: WGS), announcing the litigation on June 29, 2026.
  • The complaint alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, the principal antifraud provisions of federal securities law.
  • The firm is urging GeneDx investors who believe they suffered losses to contact it to discuss their rights.
  • The source does not specify the class period, the nature of the alleged misrepresentations, or the claimed damages.
  • GeneDx had not responded publicly as of the announcement date, and the source provides no statement from the company.

DJS Law Group has filed a class action lawsuit against GeneDx Holdings Corp. (NASDAQ: WGS), alleging the company violated federal securities statutes that prohibit fraudulent conduct in connection with the purchase or sale of securities. The Los Angeles-based law firm announced the litigation on June 29, 2026, and is urging affected investors to come forward.

The Legal Claims

The complaint targets GeneDx under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as well as Rule 10b-5 promulgated under that statute. Section 10(b) and Rule 10b-5 are the principal antifraud provisions of federal securities law, prohibiting material misstatements or omissions made in connection with securities transactions. Section 20(a) extends liability to controlling persons — typically executives or directors — who are found to have directed or participated in a primary violation.

Together, the provisions form the standard foundation for securities fraud class actions brought on behalf of shareholders who allege they were harmed by misleading corporate disclosures.

What Investors Are Being Told

DJS Law Group is alerting GeneDx investors to the pending action and encouraging those who believe they suffered losses to contact the firm to discuss their rights. Class actions of this type allow groups of similarly situated shareholders to pursue claims collectively, a structure that lowers the individual barrier to litigation in cases involving publicly traded companies.

GeneDx Holdings Corp. trades on the Nasdaq exchange under the ticker symbol WGS. The source does not specify the class period, the nature of the alleged misrepresentations, or the claimed damages.

What Comes Next

Securities class actions proceed through defined stages — lead plaintiff appointment, motion to dismiss, discovery, and, if the case survives, potential settlement or trial. The filing of a complaint is the earliest stage; courts have regularly dismissed such suits at the motion-to-dismiss phase, and litigation outcomes vary widely.

The source provides no statement from GeneDx or its representatives. The company had not responded publicly as of the announcement date.

Keep reading

All bulletins →
MarketsAugust 22, 2026

Abel leaves Berkshire Hathaway's stock picks to Buffett and portfolio manager Weschler

OMAHA, Aug. 22. Warren Buffett appears to retain control over Berkshire Hathaway's stock portfolio even after Greg Abel took over as chief executive, and portfolio manager Ted Weschler is also part of those calls. Abel, the new CEO…

2 min read
MarketsAugust 19, 2026

Nvidia starts H200 deliveries to China while Iran escalation keeps traders on watch

NEW YORK, Aug 19. Nvidia has begun shipping its H200 artificial intelligence chips to the Chinese market, the company reported, as market participants track geopolitical risks rising from an escalation in Iran

2 min read
MarketsAugust 12, 2026

OpenAI and AWS expand deal to bring Daybreak cyber models to Amazon Bedrock

SEATTLE, Aug. 12. OpenAI and Amazon Web Services have agreed to expand their partnership to include frontier cyber models, the companies said. Under the terms, OpenAI will make its Daybreak models available through the Amazon Bedrock…

2 min read

Frequently asked

Who filed the lawsuit against GeneDx and when?

The Los Angeles-based DJS Law Group filed the class action and announced it on June 29, 2026.

What legal claims does the complaint make?

It targets GeneDx under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, which prohibit material misstatements or omissions in connection with securities transactions and extend liability to controlling persons.

What ticker symbol does GeneDx trade under?

GeneDx Holdings Corp. trades on the Nasdaq exchange under the ticker symbol WGS.

What happens next in the case?

Securities class actions proceed through stages including lead plaintiff appointment, motion to dismiss, discovery, and potential settlement or trial, though courts have regularly dismissed such suits at the motion-to-dismiss phase and outcomes vary widely.